Oritain hits half a billion, but faces Companies Office scrutiny

Oritain hits half a billion, but faces Companies Office scrutiny
Grant Cochrane and director John Key discuss counterfeiting issues. (Image: Oritain)
Brent Melville
Dunedin company Oritain, which specialises in origin tracing and is valued at $558 million, may have to disclose its earnings.Last week, the biotech firm completed a US$57m (NZ$90m) raise, in a series C round led by London venture capital firm Highland Europe, which valued it at just over half a billion dollars.But while its foundation is about traceability, the firm's earnings remain opaque. It doesn’t report its financials in NZ, despite "officially" being overseas owned from December 2021. Under the Companies Ac...

More Finance

Willis can do more to fix banking competition
Finance

Andrew Body: Willis can do more to fix banking competition

A competitive banking system needs more than lower capital adequacy ratios.

Andrew Body 02 Apr 2025
Credit card issuers fear ComCom proposals
Finance

Credit card issuers fear ComCom proposals

The proposed regulations will stifle banking competition, says Mastercard.

Pattrick Smellie 02 Apr 2025
RBNZ signals U-turn on bank capital requirements
Finance

RBNZ signals U-turn on bank capital requirements

A major shift at RBNZ's first public outing since Adrian Orr's sudden departure.

Pattrick Smellie 31 Mar 2025
Grenon seeks to end ‘futile’ NZME board stoush
Finance

Grenon seeks to end ‘futile’ NZME board stoush

It's time for the current board to fold 'em, says coup orchestrator. 

Pattrick Smellie 26 Mar 2025